-------------
FORM 4
-------------
[ ] Check this box if no U.S. SECURITIES AND EXCHANGE COMMISSION --------------------------
longer subject to Washington, D.C. 20549 OMB APPROVAL
Section 16. Form 4 --------------------------
or Form 5 obligations STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OMB Number: 3235-0287
may continue. See Expires: December 31, 2001
Instruction 1(b). Estimated average burden
hours per response .. 0.5
(Print or Type Responses) --------------------------
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person(s) to
Issuer
BioTime, Inc. (BTX) (Check all applicable)
Dresner Milton H. __x__ Director _____ 10% Owner
(Last) (First) (Middle) 3. IRS or Social Security 4. Statement for ____ Officer _____ Others
Number of Reporting Month/Year (give title below) (specify below)
Person (Voluntary) 12/01 ______________________
28777 Northwestern Hwy., Suite 100
(Street) 5. If Amendment, 7. Individual or Joint/Group Filing
Date of Original (Check Applicable Line)
(Month/Year) _x_Form filed by One Reporting Person
__Form filed by More than One
Reporting Person
Southfield MI 48304
(City) (State) (Zip)
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security 2. Trans- 3. Trans 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature
(Instr. 3) action action or Disposed of (D) Securities ship of In-
Date Code (Instr. 3, 4, and 5) Beneficially Form; direct
(Instr. Owned at Direct Bene-
8) End of (D) or ficial
(Month/ Month Indirect Owner-
Day/ (I) ship
Year) (A)
or (Instr. 3 (Instr. 4)(Instr. 4)
Amount (D) Price and 4)
------------------------------------------------------------------------------------------------------------------------------------
Common Shares, no par value 12/31/01 A* 1,087 A $4.60 70,207** D
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over)
* If the form is filed by more than one reporting person, see Instruction 4(b)(v). SEC 1471 (7-96)
FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
-----------------------------------------------------------------------------------------------------------------------------------
1. Title of 2.Conver- 3. Tran- 4. Trans- 5.Number of 6. Date Exer- 7. Title and 8.Price 9. Number 10. Owner- 11. Nature
Derivative sion or action action Derivative cisable and Amount of of of ship of
Security Exercise Date Code Securities Expiration Underlying Deriv- Deriva- Form of Indirect
(Instr. 3) Price Acquired (A) Date Securities ative tive Deriva- Bene-
of (Instr . or Disposed Security Securities tive ficial
Derivative 8) of (D) (Month/Day/ (Instr. 3 (Instr. Bene- Security: Owner-
Security (Month/ (Instr. 3, 4 Year) and 4) 5) ficially Direct ship
Day/ and 5) Owned (D) or (Instr.
Year) at End Indirect 4)
Date Expir- Amount of Month (I)
(A) (D) Exer- ation Title or (Instr. 4) (Instr.4)
cisable Date Number
of
Shares
-----------------------------------------------------------------------------------------------------------------------------------
Option to Purchase Common $7.25 3/26/01 3/25/06 Common 10,000 N/A 10,000 D
Shares Shares
-----------------------------------------------------------------------------------------------------------------------------------
Option to Purchase Common $11.50 3/31/00 3/30/05 Common 10,000 N/A 10,000 D
Shares Shares
-----------------------------------------------------------------------------------------------------------------------------------
Option to Purchase Common $12.57 4/29/99 4/28/04 Common 10,000 N/A 10,000 D
Shares Shares
-----------------------------------------------------------------------------------------------------------------------------------
Warrants to Purchase Common $6.50 8/13/01 8/01/04 Common 15,385 N/A 15,385 D
Stock Shares
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
===================================================================================================================================
Explanation of Responses:
*Mr. Dresner acquired these shares in lieu of cash director's fees. The number of such shares was determined based upon the closing
price of BioTime common shares on the American Stock Exchange on the last trading day of the quarter.
**Includes 30,000 common shares that Mr. Dresner may acquire through the exercise of stock options and 15,385 common shares that Mr.
Dresner may acquire through the exercise of warrants.
** Intentional misstatements or omissions of s/Milton H. Dresner January 9, 2002
facts constitute Federal Criminal Violation. ---------------------------------- -----------------------------------
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). **Signature of Reporting Person Date
Note: File three copies of this Form, one of
which must be manually signed. If space is
insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the
collection of information contained in this
form are not required to respond unless the
form displays a valid OMB Number.
Page 2 SEC 1474 (7-96)